Janus Global Life Sciences Fund (JAGLX)
Sector Experts Seeking Growth and Innovation in Health Care

SHARE CLASS

FUND FACTS (JAGLX)

Inception Date12/31/1998
NAV (As of 3/31/15 )$59.45
Total Net Assets (As of 2/28/15)$4.03B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.93%
NET 0.93%

Performance (As of 12/31/14)
1 Year34.83%
3 Year37.82%
5 Year24.85%
10 Year13.84%
Morningstar (As of 2/28/15)
CategoryHealth
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

120 Funds Rated
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

PERFORMANCE View Time Period:
As of 3/31/15As of 2/28/15As of 12/31/14As of 12/31/14
Inception: Dec 31, 1998
PRICE1 DAY
RETURN

YTD
1 YR3 YR5 YR10 YRSINCE
INCEPTION
Class T Shares 
$59.45-1.44%13.19%30.28%37.95%27.21%15.44%13.07%34.83%37.82%24.85%13.84%12.50%34.83%161.78%203.37%265.45%557.98%
MSCI World Health Care Index9.84%
(03/30/2015)
17.27%24.67%17.94%10.25%6.36%18.10%23.67%16.22%9.49%5.99%18.10%89.14%112.01%147.65%153.48%
S&P 500® Index1.84%
(03/30/2015)
15.51%18.00%16.18%7.99%5.33%13.69%20.41%15.45%7.67%5.22%13.69%74.60%105.14%109.47%125.71%

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.

Annual Expense Ratio: Gross: 0.93% / Net: 0.93% View Fees and Expenses

RISK STATISTICS
VS. MSCI World Health Care Index

VIEW RISK STATISTICS DEFINITIONS

Alpha
Compares the risk-adjusted performance of a portfolio to a benchmark index.
Beta
A measure of the volatility of a portfolio in comparison to a benchmark index.
R-Squared
Represents the percentage of the portfolio’s performance that can be explained by the general movements of a benchmark index.
Standard Deviation
Measures historical volatility.
Sharpe Ratio
Measures risk-adjusted performance by dividing the portfolio’s excess returns by the standard deviation of those returns.
Information Ratio
Measure of a portfolio management’s performance against risk and return relative to a benchmark or alternative measure.
FUNDINDEX
Alpha11.397.71N/AN/A
Beta0.991.031.001.00
R-Squared (%)57.3171.29100.00100.00
Standard Deviation12.7513.889.7211.35
Sharpe Ratio2.971.962.531.57
Information Ratio1.591.25----

Statistics are for the Fund’s “parent” share class (typically that with the longest history).

MORNINGSTAR PERCENTILEView Time Period:
As of 12/31/14As of 2/28/15
1 YR3 YR5 YR10 YRSINCE
INCEPTION
Percentile Ranking (%)216242921620273121
Health Category
Rank/Count
3 / 12820 / 12330 / 12234 / 11715 / 708 / 12825 / 12333 / 12237 / 11715 / 70

CALENDAR YEAR PERFORMANCE

GROWTH OF A $10,000 HYPOTHETICAL INVESTMENT

UP AND DOWN MARKET CAPTURE

AS OF 2/28/153 YR UP MARKET
CAPTURE
3 YR DOWN MARKET
CAPTURE
5 YR UP MARKET
CAPTURE
5 YR DOWN MARKET
CAPTURE
Janus Global Life Sciences Fund139.16%74.31%130.48%88.71%
MSCI World Health Care Index100.00%100.00%100.00%100.00%

Statistics are for the Fund’s “parent” share class (typically that with the longest history).

ANNUAL FEES & EXPENSES

AS OF FISCAL YEAR END 9/30/2014
CLASS T SHARES
Management Fees0.64%
12b-1 FeesN/A
Other Expenses0.29%
Total Gross Expenses0.93%
WaiversN/A
TOTAL NET EXPENSES0.93%